Feilong Chen

机构：Dalian University of Technology, Southern University of Science and Technology · ORCID：0000-0002-3253-8097

发表论文 52 篇 · 总被引 602 次 · h-index 12

代表论文

• Keap1-Nrf2 pathway: a key mechanism in the occurrence and development of cancer (2024 · Frontiers in Oncology · 被引 80)
• The pivotal role of TGF-β/Smad pathway in fibrosis pathogenesis and treatment (2025 · Frontiers in Oncology · 被引 59)
• Gene therapy for genetic diseases: challenges and future directions (2025 · MedComm · 被引 27)
• Gegen Qinlian decoction restores the intestinal barrier in bacterial diarrhea piglets by promoting Lactobacillus growth and inhibiting the TLR2/MyD88/NF-κB pathway (2022 · Biomedicine & Pharmacotherapy · 被引 21)
• Glyceollin biosynthesis in a plant chassis engineered for isoflavone production (2025 · Nature Chemical Biology · 被引 19)
• Divergent multifunctional P450s-empowered biosynthesis of bioactive tripterifordin and cryptic atiserenoids in Aconitum implies convergent evolution (2025 · Nature Communications · 被引 13)